An Observational Study Called ROVER to Learn More About How Well Vericiguat Works in People Who Were Newly Treated With Vericiguat in Routine Medical Care in Germany

CompletedOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

July 5, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions

Chronic Heart Failure With Reduced Ejection Fraction

Interventions

DRUG

Vericiguat (Verquvo, BAY1021189)

Vericiguat was given following routine clinical practice.

Trial Locations (1)

Bayer, Wuppertal